Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic, British Journal of Cancer, vol.1, issue.7, pp.1681-1688, 2014. ,
DOI : 10.1007/s10549-012-2089-2
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation, Familial Cancer, vol.10, issue.6, pp.97-103, 2005. ,
DOI : 10.1007/s10689-005-4215-3
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data, The Lancet, vol.381, issue.9880, pp.1827-1861, 2013. ,
DOI : 10.1016/S0140-6736(13)60140-3
Tamoxifen chemoprevention?end of the road? Journal of the Amercican Medical Association Oncology, pp.1033-1037, 2015. ,
Preventive Services Task Force. Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, vol.159, pp.698-708, 2013. ,
Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline, Journal of Clinical Oncology, vol.31, issue.23, pp.2942-62, 2013. ,
DOI : 10.1200/JCO.2013.49.3122
testing: risk reduction and surveillance, Cancer, vol.138, issue.2, pp.510-517, 2012. ,
DOI : 10.1001/archsurg.138.12.1323
Women's views on chemoprevention of breast cancer: qualitative study, Can Fam Physician, vol.52, pp.625-332, 2006. ,
Women???s decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid, Breast Cancer Research and Treatment, vol.319, issue.7212, pp.613-633, 2010. ,
DOI : 10.1136/bmj.319.7212.731
Acceptability and Adherence in a Chemoprevention Trial among Women at Increased Risk for Breast Cancer Attending the Modena Familial Breast and Ovarian Cancer Center (Italy), The Breast Journal, vol.3, issue.1, pp.10-21, 2013. ,
DOI : 10.1158/1940-6207.CAPR-10-0096
Tamoxifen for the Prevention of Breast Cancer: Psychosocial Impact on Women Participating in Two Randomized Controlled Trials, Journal of Clinical Oncology, vol.19, issue.7, pp.1885-92, 2001. ,
DOI : 10.1200/JCO.2001.19.7.1885
Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction, Cancer, vol.85, issue.10, pp.1996-2005, 2005. ,
DOI : 10.7326/0003-4819-137-1-200207020-00014
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis, Annals of Oncology, vol.27, issue.4, pp.575-90, 2016. ,
DOI : 10.1093/annonc/mdv590
How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide, Breast Cancer Research and Treatment, vol.216, issue.2, pp.153-162, 2005. ,
DOI : 10.3181/00379727-216-44176
The Distinct Role of Comparative Risk Perceptions in a Breast Cancer Prevention Program, Annals of Behavioral Medicine, vol.54, issue.2, pp.262-270, 2011. ,
DOI : 10.1037/0003-066X.54.2.93
Addressing the Support Needs of Women at High Risk for Breast Cancer: Evidence-Based Care by Advanced Practice Nurses, Oncology Nursing Forum, vol.29, issue.6, pp.77-84, 2002. ,
DOI : 10.1188/02.ONF.E77-E84
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement, PLoS Medicine, vol.6, issue.7, p.10000097, 2009. ,
Atypia in Random Periareolar Fine-Needle Aspiration Affects the Decision of Women at High Risk to Take Tamoxifen for Breast Cancer Chemoprevention, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.5, pp.1032-1036, 2007. ,
DOI : 10.1158/1055-9965.EPI-06-0910
Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another, Cancer, vol.15, issue.4, pp.959-68, 2001. ,
DOI : 10.1155/1999/140498
The Feasibility of Women at High Risk for Breast Cancer Participating in Chemoprevention Trials, Journal of Psychosocial Oncology, vol.352, issue.4, pp.31-45, 2004. ,
DOI : 10.1200/JCO.20.5.1260
???Why take it if you don???t have anything???? breast cancer risk perceptions and prevention choices at a public hospital, Journal of General Internal Medicine, vol.118, issue.7, pp.779-85, 2006. ,
DOI : 10.1002/ajmg.a.10150
Living My Family???s Story, Cancer Nursing, vol.35, issue.6, pp.493-504, 2012. ,
DOI : 10.1097/NCC.0b013e31824530fa
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635541/pdf
Women's Decision Making About Whether or Not to Use Breast Cancer Chemoprevention, Women & Health, vol.7, issue.2, pp.81-95, 2005. ,
DOI : 10.1007/BF02895155
Decision-Making About Tamoxifen in Women at High Risk for Breast Cancer: Clinical and Psychological Factors, Journal of Clinical Oncology, vol.22, issue.24, pp.4951-4958, 2004. ,
DOI : 10.1200/JCO.2004.05.192
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations, European Journal of Human Genetics, vol.91, issue.5, pp.500-506, 2011. ,
DOI : 10.1016/j.ejca.2006.09.009
URL : https://hal.archives-ouvertes.fr/hal-00697966
Attitudes to Prophylactic Surgery and Chemoprevention in Australian Women at Increased Risk for Breast Cancer, Journal of Women's Health, vol.12, issue.8, pp.769-78, 2003. ,
DOI : 10.1089/154099903322447738
I'm going to die of something anyway " : women's perceptions of tamoxifen for breast cancer risk reduction, Ethn Dis, vol.15, issue.3, pp.365-72, 2005. ,
Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis, Journal of Clinical Oncology, vol.28, issue.18, pp.3090-3095, 2010. ,
DOI : 10.1200/JCO.2009.27.8077
Women???s interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid, Breast Cancer Research and Treatment, vol.18, issue.11, pp.681-689, 2011. ,
DOI : 10.1037/0022-3514.65.1.113
Healthy Women with a Family History of Breast Cancer: Impact of a Tailored Genetic Counseling Intervention on Risk Perception, Knowledge, and Menopausal Therapy Decision Making, Journal of Women's Health, vol.15, issue.7, pp.843-56, 2006. ,
DOI : 10.1089/jwh.2006.15.843
Tamoxifen For Breast Cancer Chemoprevention: Low Uptake by High-Risk Women After Evaluation of a Breast Lump, The Annals of Family Medicine, vol.3, issue.3, pp.242-249, 2005. ,
DOI : 10.1370/afm.284
Breast cancer anxiety's associations with responses to a chemoprevention decision aid, Social Science & Medicine, vol.77, issue.0, pp.77-90, 2013. ,
DOI : 10.1016/j.socscimed.2012.10.009
Decision making in cancer primary prevention and chemoprevention, Annals of Behavioral Medicine, vol.334, issue.5, pp.179-87, 2006. ,
DOI : 10.1093/jnci/dji306
Interest in breast cancer chemoprevention among older women, Breast Cancer Research and Treatment, vol.137, issue.1 Suppl, pp.435-53, 2008. ,
DOI : 10.7326/0003-4819-137-1-200207020-00014
The Effect of Physician Recommendation on Enrollment in the Breast Cancer Chemoprevention Trial, Preventive Medicine, vol.27, issue.5, pp.713-722, 1998. ,
DOI : 10.1006/pmed.1998.0349
Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment, Cancer, vol.12, issue.1, pp.46-56, 1995. ,
DOI : 10.1177/109019818801500203
Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer, Cancer Epidemiol Biomarkers Prev, vol.7, pp.591-596, 1998. ,
Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention, Annals of Surgical Oncology, vol.281, issue.7, pp.580-585, 2001. ,
DOI : 10.1016/S0140-6736(98)85012-5
Chemoprevention of breast cancer with selective estrogen receptor modulators: views from broadly diverse focus groups of women with elevated risk for breast cancer, Psycho-Oncology, vol.88, issue.6, pp.521-554, 2001. ,
DOI : 10.1093/jnci/88.16.1100
Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial, Breast Cancer Research and Treatment, vol.101, issue.6, pp.101-111, 2010. ,
DOI : 10.7326/0003-4819-148-5-200803040-00004
URL : https://hal.archives-ouvertes.fr/hal-00519614
Results of an Intervention for Individuals and Families with BRCA Mutations: A Model for Providing Medical Updates and Psychosocial Support Following Genetic Testing, Journal of Genetic Counseling, vol.378, issue.12, pp.433-56, 2007. ,
DOI : 10.1097/00006842-197905000-00004
Psychological and Clinical Factors Implicated in Decision Making About a Trial of Low-Dose Tamoxifen in Hormone Replacement Therapy Users, Journal of Clinical Oncology, vol.26, issue.9, pp.1537-1580, 2008. ,
DOI : 10.1200/JCO.2007.13.6739
Acceptance of tamoxifen chemoprevention by physicians and women at risk, Cancer, vol.137, issue.9, pp.1800-1806, 2004. ,
DOI : 10.7326/0003-4819-137-1-200207020-00017
Association of Risk-Reducing Surgery in <emph type="ital">BRCA1</emph> or <emph type="ital">BRCA2</emph> Mutation Carriers With Cancer Risk and Mortality, JAMA, vol.304, issue.9, pp.967-75, 2010. ,
DOI : 10.1001/jama.2010.1237
Acceptability of cancer chemoprevention trials: impact of the design, International Journal of Medical Sciences ,
DOI : 10.7150/ijms.5.244
Intention to Undergo Prophylactic Bilateral Mastectomy in Women at Increased Risk of Developing Hereditary Breast Cancer, Journal of Clinical Oncology, vol.18, issue.11, pp.2250-2257, 2000. ,
DOI : 10.1200/JCO.2000.18.11.2250
Emotional and behavioural responses, in Stress and medical procedures, Oxford: Oxford Science, pp.25-57, 1989. ,
Genetic susceptibility testing from a stress and coping perspective, Social Science & Medicine, vol.62, issue.8, pp.1880-90, 2006. ,
DOI : 10.1016/j.socscimed.2005.08.041
Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research, Social Science & Medicine, vol.62, issue.6, pp.1360-1368, 2006. ,
DOI : 10.1016/j.socscimed.2005.08.005
Evaluating the effectiveness of health belief model interventions in improving adherence: a systematic review, Health Psychology Review, vol.26, issue.3, pp.253-69, 2014. ,
DOI : 10.1037/0278-6133.22.1.99
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers, Breast Cancer Research and Treatment, vol.22, issue.2, pp.421-428, 2014. ,
DOI : 10.1093/annonc/mdq427
iPrevent??: a tailored, web-based, decision support tool for breast cancer risk assessment and management, Breast Cancer Research and Treatment, vol.21, issue.7, pp.171-82, 2016. ,
DOI : 10.5694/mja13.10848
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial, The Lancet Oncology, vol.16, issue.1, pp.67-75, 2015. ,
DOI : 10.1016/S1470-2045(14)71171-4